Table 2 GOLD 2013, clinical phenotypes and BODEx index by GOLD 2007 classification
GOLD 20071 | ||||
|---|---|---|---|---|
Moderate n (%) | Severe n (%) | Very-severe n (%) | ||
GOLD 2013 2 | A | 28 (20.7%) | 0 (0.0%) | 0 (0.0%) |
B | 66 (48.9%) | 0 (0.0%) | 0 (0.0%) | |
C | 6 (4.4%) | 22 (15.2%) | 2 (3.0%) | |
D | 35 (25.9%) | 123 (84.8%) | 64 (97.0%) | |
Clinical phenotype (GesEPOC) | Non exacerbator | 86 (68.8%) | 88 (64.2%) | 33 (55.0%) |
COPD-asthma overlap | 13 (10.4%) | 7 (5.1%) | 1 (1.7%) | |
Exacerbator with emphysema | 9 (7.2%) | 18 (13.1%) | 14 (23.3%) | |
Exacerbator with chronic bronchitis | 17 (13.6%) | 24 (17.5%) | 12 (20.0%) | |
BODEx index classification | 0-2 | 124 (91.9%) | 43 (29.7%) | 0 (0.0%) |
3-4 | 9 (6.7%) | 72 (49.7%) | 12 (18.2%) | |
5-6 | 2 (1.5%) | 27 (18.6%) | 46 (69.7%) | |
7-9 | 0 (0.0%) | 3 (2.1%) | 8 (12.1%) | |